Bruker and Waters: Can we get some clarification?

March 10, 2006
Waters Corp. was proud to announce its new collaboration with Bruker BioSciences this week in a Wednesday press release. Just one problem: It seems it forgot to tell Bruker, which offered this curt reply (read below for Waters' original release): BILLERICA, Mass.--(BUSINESS WIRE)--March 9, 2006--Bruker BioSciences Corporation (NASDAQ: BRKR) today said that it is surprised to see that Waters Corporation (NYSE: WAT) issued a press release on March 8, 2006 with the title "Waters Corporation and Bruker BioSciences Announce Collaboration". That press release has been neither approved nor authorized by Bruker BioSciences, and Bruker BioSciences has in fact not made such an announcement. Bruker BioSciences believes that this is a case of a simple error. The Waters announcement: MILFORD, Mass., March 8 /PRNewswire-FirstCall/ -- Waters Corporation and Bruker BioSciences Corporation , Billerica, MA, have entered into a collaboration agreement to provide greater integration and connectivity between Waters(R) ACQUITY Ultra Performance LC(TM) (UPLC(TM)) system and Bruker's mass spectrometry (MS) and nuclear magnetic resonance (NMR) products. The collaboration will allow direct support of Waters ACQUITY UPLC System in Bruker's HyStar(TM) software thus unifying control and results management to seamlessly combine these complementary technologies. The products of both companies play an important role in the discovery, development, and manufacture of pharmaceuticals, processed foods, beverages, personal care products, and in environmental and food safety laboratories. "Scientists are always looking for a competitive edge and many have experienced the advantages of using UPLC with MS," said Rohit Khanna, Ph.D., Vice President -- Worldwide Marketing, Waters Corporation. "Combining UPLC with mass spectrometry brings scientists measurable improvements in performance and in the overall quality of information they obtain from their LC/MS and LC/NMR analyses resulting in improved decision-making, increased productivity and reduced business risk." UPLC and MS -- A Natural Fit Mass spectrometry results are highly-dependent on the liquid chromatography separation preceding ionization and confirmatory analysis in the mass spectrometer. Compared to conventional high performance liquid chromatography (HPLC), UPLC results are significantly better -- peaks are narrower and sharper, signal-to-noise ratios are higher, peak capacity is greater, run times are shorter -- which are all key factors in reducing the effects of ion suppression and enhancing the performance of virtually any mass spectrometer, thus bringing laboratories new levels of efficiency. For Waters and Bruker customers, the seamless combination of UPLC technology with mass spectrometry promises to bring their laboratories more information per unit of time resulting in greater productivity. -- PWT
Waters Corp. was proud to announce its new collaboration with Bruker BioSciences this week in a Wednesday press release. Just one problem: It seems it forgot to tell Bruker, which offered this curt reply (read below for Waters' original release): BILLERICA, Mass.--(BUSINESS WIRE)--March 9, 2006--Bruker BioSciences Corporation (NASDAQ: BRKR) today said that it is surprised to see that Waters Corporation (NYSE: WAT) issued a press release on March 8, 2006 with the title "Waters Corporation and Bruker BioSciences Announce Collaboration". That press release has been neither approved nor authorized by Bruker BioSciences, and Bruker BioSciences has in fact not made such an announcement. Bruker BioSciences believes that this is a case of a simple error. The Waters announcement: MILFORD, Mass., March 8 /PRNewswire-FirstCall/ -- Waters Corporation and Bruker BioSciences Corporation , Billerica, MA, have entered into a collaboration agreement to provide greater integration and connectivity between Waters(R) ACQUITY Ultra Performance LC(TM) (UPLC(TM)) system and Bruker's mass spectrometry (MS) and nuclear magnetic resonance (NMR) products. The collaboration will allow direct support of Waters ACQUITY UPLC System in Bruker's HyStar(TM) software thus unifying control and results management to seamlessly combine these complementary technologies. The products of both companies play an important role in the discovery, development, and manufacture of pharmaceuticals, processed foods, beverages, personal care products, and in environmental and food safety laboratories. "Scientists are always looking for a competitive edge and many have experienced the advantages of using UPLC with MS," said Rohit Khanna, Ph.D., Vice President -- Worldwide Marketing, Waters Corporation. "Combining UPLC with mass spectrometry brings scientists measurable improvements in performance and in the overall quality of information they obtain from their LC/MS and LC/NMR analyses resulting in improved decision-making, increased productivity and reduced business risk." UPLC and MS -- A Natural Fit Mass spectrometry results are highly-dependent on the liquid chromatography separation preceding ionization and confirmatory analysis in the mass spectrometer. Compared to conventional high performance liquid chromatography (HPLC), UPLC results are significantly better -- peaks are narrower and sharper, signal-to-noise ratios are higher, peak capacity is greater, run times are shorter -- which are all key factors in reducing the effects of ion suppression and enhancing the performance of virtually any mass spectrometer, thus bringing laboratories new levels of efficiency. For Waters and Bruker customers, the seamless combination of UPLC technology with mass spectrometry promises to bring their laboratories more information per unit of time resulting in greater productivity. -- PWT
About the Author

pharmamanufacturing | pharmamanufacturing